Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

Author(s): van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, et al.

Abstract

Postmortem unfixed whole brains from five multiple sclerosis (MS) patients were examined by MRI using a T2- and T1-weighted spin-echo (SE) sequence and histology to investigate the histopathologic characteristics of hypointense lesions on T1-weighted SE MR images. The degree of hypointensity was scored semiquantitatively by two blinded observers in reference to normal-appearing white matter. Signal intensities of the lesions and the normal-appearing white matter were measured to obtain contrast ratios. Hematoxylin-eosin stain was used to assess degree of matrix destruction (decrease of density of the neuropil) and cellularity of a lesion, Klüver-Barrera stain for degree of demyelination, Bodian stain for axonal density, and immunostaining of glial fibrillary acid protein for reactive astrocytes and fibrillary gliosis. Nineteen lesions were selected for analysis. Nearly all lesions were compatible with the chronic MS plaque: hypocellularity, absence of myelinated axons, in the presence of reactive astrocytes. Contrast ratios of the lesions were highly correlated (R = -0.90; p < 0.01), with degree of hypointensity scored semiquantitatively. Degree of hypointensity on T1-weighted SE images did not correlate with degree of demyelination or number of reactive astrocytes, but was associated with axonal density (R = -0.71; p = 0.001). A trend was found with degree of matrix destruction (R = 0.45; p = 0.052). We conclude that, in our limited sample, hypointense lesions seen on T1-weighted SE MR images are associated histopathologically with severe tissue destruction, including axonal loss. Our results need to be substantiated in a larger study on more varied patient material to evaluate the use of hypointense lesions as a surrogate marker of persistent deficit in MS patients.

Similar Articles

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study

Author(s): Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, et al.

Axonal transection in the lesions of multiple sclerosis

Author(s): Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, et al.

Magnetic resonance frequency shifts during acute MS lesion formation

Author(s): Wiggermann V, Hernández Torres E, Vavasour IM, Moore GR, Laule C, et al.

Weekly diffusion-weighted imaging of normal-appearing white matter in MS

Author(s): Rocca MA, Cercignani M, Iannucci G, Comi G, Filippi M

MRI in multiple sclerosis: current status and future prospects

Author(s): Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, et al.

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T

Author(s): Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, et al.

Diffusion tensor magnetic resonance imaging in multiple sclerosis

Author(s): Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G

Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis

Author(s): Narayana PA, Zhou Y, Hasan KM, Datta S, Sun X, et al.

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis

Author(s): Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, et al.

Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis

Author(s): Radü EW, Bendfeldt K, Mueller-Lenke N, Magon S, Sprenger T

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Author(s): Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al.

Clinical correlations of brain lesion distribution in multiple sclerosis

Author(s): Vellinga MM, Geurts JJ, Rostrup E, Uitdehaag BM, Polman CH, et al.

Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR

Author(s): van Waesberghe JH, van Walderveen MA, Castelijns JA, Scheltens P, Lycklama à Nijeholt GJ, et al.

Measuring myelin repair and axonal loss with diffusion tensor imaging

Author(s): Fox RJ, Cronin T, Lin J, Wang X, Sakaie K, et al.

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

Author(s): Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, et al.

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis

Author(s): Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, et al.

Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features

Author(s): Tubridy N, Coles AJ, Molyneux P, Compston DA, Barkhof F, et al.

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

Author(s): Barkhof F, Held U, Simon JH, Daumer M, Fazekas F, et al.

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis

Author(s): Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, et al.